This randomized clinical trial studies enhanced quitline intervention in smoking cessation
for patients with non-metastatic lung cancer. Stop-smoking plans suggested by doctors may
help patients with early-stage cancer quit smoking
Other: questionnaire administration
Procedure: quality-of-life assessment
Other: counseling intervention
Other: internet-based intervention
Behavioral: telephone-based intervention
Other: educational intervention
Drug: nicotine replacement therapy
Other: educational intervention
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT01457469
Ages eligible for Study
18 Years and older
Genders eligible for Study
Accepts Healthy Volunteers
Diagnosed with American Joint Committee on Cancer (AJCC) stage I-IIIa/b non-small cell lung cancer or limited stage small cell lung cancer Smoked any cigarettes in the past seven days Willing to consider quitting smoking
Patients with drug and alcohol abuse:
All patients will be assessed for alcohol use using a validated 1-item screening question; if positive, patients will be assessed using the validated Alcohol Use Disorders Identification Test (AUDIT) screening instrument, those with scores >= 8
(the validated cutoff) will be excluded
All patients will be assessed for drug use using a 1-item screening question: "How many times in the past month have you used an illegal drug or used a prescription medication for non-medical reasons?"; those with a response of >= 1 will be excluded Patient is unable to comprehend study documents and provide informed consent or Eastern Cooperative Oncology Group (ECOG) performance status is greater than two Patient does not read or understand English Patient refuses to participate Patient is contraindicated to receive nicotine replacement therapy: a) Patient is pregnant or breastfeeding, b) Patient has unstable cardiac disease within the past month (defined as unstable angina, myocardial infarction, serious arrhythmias, or any cardiac intervention procedure), or c) Patient is currently taking Chantix Patient does not have regular access to a phone to receive calls from the quitline
All locations for NCT01457469
United States (1)
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States, 27157
View full eligibility
Tris trial is registered with FDA with number: NCT01457469. The sponsor of the trial is Wake Forest University Health Sciences and it is looking for 6 volunteers for the current phase.
Official trial title: Adapting Smoking Cessation Interventions for the Outpatient Oncology Setting
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.